covid
Buscar en
Infectio
Toda la web
Inicio Infectio VIH y psoriasis en un minero de Colombia
Journal Information
Vol. 14. Issue 4.
Pages 286-291 (December 2010)
Share
Share
Download PDF
More article options
Vol. 14. Issue 4.
Pages 286-291 (December 2010)
Open Access
VIH y psoriasis en un minero de Colombia
HIV and psoriasis in a Colombian miner – Case report
Visits
2016
Carlos Pérez1,*, Eliana Andrea Merlo2, Lina María Murcia3, Nelcy Teresa Guerra3, Silvana Orozco3, Christian Flórez4
1 Jefe de Infectología, Hospital Universitario la Samaritana, Universidad de la Sabana, Bogotá, D.C., Colombia
2 Residente de Dermatología, Universidad El Bosque, Bogotá, D. C., Colombia
3 Residente de Medicina Interna, Universidad de la Sabana, Bogotá, D.C., Colombia
4 Residente de Medicina Interna, Universidad Militar Nueva Granada, Bogotá, D.C., Colombia
This item has received

Under a Creative Commons license
Article information
Resumen

La incidencia de psoriasis en la población general se encuentra alrededor de 1% a 2%, similar a la encontrada en pacientes con virus de la inmunodeficiencia humana (VIH) en quienes, a pesar de cursar con una respuesta Th1 disminuida, se presenta con mayor intensidad y es más resistente a los tratamientos convencionales.

Presentamos el caso de un paciente con VIH y lesiones cutáneas extensas que comprometían la mayor parte de la superficie corporal. Después de recibir tratamiento con metotrexato, iniciado por el compromiso cutáneo, se evidenció resolución de las lesiones.

Debe tenerse en cuenta que la presentación de enfermedades cutáneas varía en estados de inmunosupresión y, asimismo, el manejo que se proponga debe ser aquél que no empeore su estado y que no interactúe con la terapia antirretroviral.

Palabras clave:
psoriasis
virus de la inmunodeficiencia humana
inmunosupresión
Abstract

The incidence of psoriasis in general population ranges from 1 to 2%, similar to that found in patients with HIV, who despite having a diminished Th1 response, are affected by a more severe form of the psoriatic disease and more refractory to conventional treatments.

We present the case of a patient with HIV and severe skin lesions, compromising most of the body surface. After receiving a methotrexate therapy, started due the extensive cutaneous involvement, an improvement of the lesions was evidenced. It should be noted that the presentation of skin diseases varies in the different states of immunosuppression, and likewise, the proposed treatment must be the one that does not worsen their condition and does not interact with antiretroviral drugs.

Key words:
Psoriasis
Human Immunodeficiency Virus
immunosuppression
Full text is only aviable in PDF
Referencias
[1.]
R.V. Patel, J.M. Weinberg.
Psoriasis in the patient with human immunodeficiency virus, part 1: Review of pathogenesis.
Cutis, 82 (2008), pp. 117-122
[2.]
J.M. Gelfand, D. Rudikoff.
Evaluation and treatment of itching in HIV-infected patients.
Mt Sinai J Med, 68 (2001), pp. 298-308
[3.]
N. Morar, S.A. Willis-Owen, T. Maurer, C.B. Bunker.
HIV-associated psoriasis: Pathogenesis, clinical features, and management.
Lancet Infect Dis, 10 (2010), pp. 470-478
[4.]
I. Mamkin, A. Mamkin, S.V. Ramanan.
HIV-associated psoriasis.
Lancet Infect Dis, 7 (2007), pp. 496
[5.]
F. Singh, D. Rudikoff.
HIV-associated pruritus: Etiology and management.
Am J Clin Dermatol, 4 (2003), pp. 177-188
[6.]
D. Fife, J. Waller, E. Jeffes.
Unraveling the paradoxes of HIV-associated psoriasis: A review of T-cell subsets and cytokine profiles.
Dermatology Online J, 13 (2007), pp. 4
[7.]
M. Echeverri, A. Londoño, M. Velázquez.
Papel de las células Th17 en la inmunopatogénesis de la psoriasis.
Rev Asoc Colomb Dermatol, 17 (2009), pp. S3-S9
[8.]
L. Vittorio, G. De Socio, S. Simonetti, G. Stagni.
Clinical improvement of psoriasis in an AIDS patient effectively treated with combination antiretroviral therapy.
Scand J Infect Dis, 38 (2006), pp. 74-75
[9.]
K. Menon, A.S. van Voorhees, B.F. Bebo Jr., D.D. Gladman, S. Hsu, R. Kalb.
HIV-associated psoriasis: Pathogenesis, clinical features and management of the National Psoriasis Foundation.
J Am Acad Dermatol, 62 (2010), pp. 291-299
[10.]
L. Leal, M. Ribera, E. Dauden.
Psoriasis and HIV infection.
Actas Dermosifiliograf, 99 (2008), pp. 753-763
[11.]
J. Breuer-McHam, G. Marshall, A. Adu-Oppong, M. Goller, S. Mays, T. Berger, et al.
Alterations in HIV expression in AIDS patients with psoriasis or pruritus treated with phototherapy.
J Am Acad Dermatol, 40 (1999), pp. 48-60
[12.]
C.S. Lee, K. Li.
A review of acitretin for the treatment of psoriasis.
Expert Opin Drug Saf, 8 (2009), pp. 769-779
[13.]
R.V. Patel, J.M. Weinberg.
Psoriasis in the patient with human immunodeficiency virus Part 2: Review of treatment.
Cutis, 82 (2008), pp. 202-210
[14.]
J. Chalela, D. González, L. Castro.
Guías de manejo de psoriasis Consenso Colombiano.
Asociación Colombiana de Dermatología y Cirugía Dermatológica, (2008),
[15.]
K.P. Vega.
Rheumatic manifestations in patients with HIV infection.
Acta Med Colomb, 35 (2010), pp. 15-20
[16.]
J.T. Trent, F.A. Kerdel.
Successful treatment of von Zumbusch pustular psoriasis with infliximab.
J Cutan Med Surg, 8 (2004), pp. 224-228
[17.]
D. Barco, L. Puig, A. Alomar.
Treatment of moderate-severe psoriasis with etanercept in patients with chronic human immunodeficiency virus infection.
Actas Dermosifiliogr, 101 (2010), pp. 77-81
Copyright © 2010. Asociación Colombiana de Infectología (ACIN)
Download PDF
Article options